These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11423973)

  • 1. Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice.
    Powell DJ; Russell JP; Li G; Kuo BA; Fidanza V; Huebner K; Rothstein JL
    Oncogene; 2001 May; 20(25):3235-46. PubMed ID: 11423973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
    Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
    Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.
    Basolo F; Giannini R; Monaco C; Melillo RM; Carlomagno F; Pancrazi M; Salvatore G; Chiappetta G; Pacini F; Elisei R; Miccoli P; Pinchera A; Fusco A; Santoro M
    Am J Pathol; 2002 Jan; 160(1):247-54. PubMed ID: 11786418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid carcinomas in RET/PTC transgenic mice.
    Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
    Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A thyroid tumor-specific antigen formed by the fusion of two self proteins.
    Powell DJ; Eisenlohr LC; Rothstein JL
    J Immunol; 2003 Jan; 170(2):861-9. PubMed ID: 12517951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.
    Santoro M; Grieco M; Melillo RM; Fusco A; Vecchio G
    Eur J Endocrinol; 1995 Nov; 133(5):513-22. PubMed ID: 7581978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
    Castellone MD; Cirafici AM; De Vita G; De Falco V; Malorni L; Tallini G; Fagin JA; Fusco A; Melillo RM; Santoro M
    Oncogene; 2003 Jan; 22(2):246-55. PubMed ID: 12527893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.
    Shinohara S; Rothstein JL
    Oncogene; 2004 Sep; 23(45):7571-9. PubMed ID: 15326486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
    Bongarzone I; Butti MG; Coronelli S; Borrello MG; Santoro M; Mondellini P; Pilotti S; Fusco A; Della Porta G; Pierotti MA
    Cancer Res; 1994 Jun; 54(11):2979-85. PubMed ID: 8187085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
    Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
    Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
    Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
    Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
    Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
    Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
    J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenes and thyroid cancer.
    Vecchio G; Santoro M
    Clin Chem Lab Med; 2000 Feb; 38(2):113-6. PubMed ID: 10834397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma.
    Jhiang SM; Smanik PA; Mazzaferri EL
    Cancer Lett; 1994 Apr; 78(1-3):69-76. PubMed ID: 8180971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells.
    Miyagi E; Braga-Basaria M; Hardy E; Vasko V; Burman KD; Jhiang S; Saji M; Ringel MD
    Mol Carcinog; 2004 Oct; 41(2):98-107. PubMed ID: 15378648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.